Section 5119.367 | [Repealed effective 6/29/2019 by H.B. 111, 132nd General Assembly] On-site reviews.
The director of mental health and addiction services shall annually conduct an on-site review of each community mental health services provider and community addiction services provider that is an opioid treatment program described in division (D)(2)(b) of section 4729.291 of the Revised Code. The review may include an inspection of pharmacy records as described in section 3719.13 of the Revised Code and an inspection of patient treatment records. If the director has reason to believe that a violation of local, state, or federal drug law, including any provision of Chapter 2925., 3715., 3719., or 4729. of the Revised Code, has occurred, the director shall report that information to the state board of pharmacy.
The director may adopt rules in accordance with Chapter 119. of the Revised Code to implement this section.
Last updated August 8, 2023 at 11:11 AM
Available Versions of this Section
- July 1, 2017 – Senate Bill 319 - 131st General Assembly [ View July 1, 2017 Version ]
- October 3, 2023 – Enacted by House Bill 33 - 135th General Assembly [ View October 3, 2023 Version ]